Effects of salmeterol on secretion of phosphatidylcholine by alveolar type II cells

Life Sciences

Volumn 66, Issue 17, 2000, Pages 1639-1646

  Kumar, Vasanth H S ^a   Christian, Constance ^a   Kresch, Mitchell J ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic receptor; Phosphatidylcholine; Salmeterol; Surfactant secretion; Type II cells

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LACTATE DEHYDROGENASE; LONG ACTING DRUG; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PROPRANOLOL; SALMETEROL; TERBUTALINE;

ANIMAL CELL; ARTICLE; CELL SECRETION; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; LUNG ALVEOLUS CELL TYPE 2; MALE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; RAT; RECEPTOR DOWN REGULATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ANIMALS; EPITHELIAL CELLS; L-LACTATE DEHYDROGENASE; MALE; PHOSPHATIDYLCHOLINES; PROPRANOLOL; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0034677971     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00483-5     Document Type: Article

References (25)

1. R.J. Mason, L.G. Dobbs, R.D. Greenleaf, and M.C. Williams, Fed. Proc. 36 2697-2702 (1977).
2. R.J. King and J.A. Clements, Am. J. Physiol. 223 715-725 (1972).
3. S.A. Rooney, Am. Rev. Respir. Dis. 131 439-460 (1985).
4. L.G. Dobbs and R.J. Mason, J. Clin. Invest. 63 378-387 (1979).
5. J.R. Wright and L.G. Dobbs, Ann. Rev. Physiol. 53 395-414 (1991).
6. A. Chander and A.B. Fisher, Am. J. Physiol. 258 L241-L253 (1990).
7. S.A Rooney, L.I. Gobran, and M. Griese, Prog. Resp. Res. 27 84-91 (1994).
8. L.G. Dobbs, R.J. Mason, and M.C. Williams, B.J. Benson, K. Sueishi, Biochim. Biophys. Acta 713 118-127 (1982).
9. L.A.S. Brown and W.J. Longmore, J. Biol. Chem. 256 66-72 (1981).
10. M.J. Kresch and I Gross, Clinics in Perinatology 14 481-507 (1987).
11. S.A. Rooney, S.L. Young, and C.R. Mendelson, FASEB. J. 8 957-967 (1994).
12. M. Johnson, P.R. Butchers, R.A. Coleman, A.T. Nials, P. Strong, M.J. Sumner, and L.J. Vardey, Life Science. 52 2131-2143 (1993).
13. M.J. Kresch, D.M. Lima, and H. Lu, Biochimica et Biophysica Acta 1299 39-46 (1996).
14. L.G. Dobbs, R. Gonzalez, and M.C. Williams, Am. Rev. Respir. Dis. 134 141-145 (1986).
15. E.C. Bligh and W.J. Dyer, Can. J. Biochem. 37 911-917 (1959).
16. F. Wroblewski and J.S. Ladue, Proc. Soc. Exp. Biol. Med. 90 210-213 (1955).
17. A.T. Nials, M.J. Sumner, M. Johnson, and A.R. Coleman, Br. J. Pharmacol. 108 507-515 (1993).
18. M.J. Kresch, D.W. Dynia, and I. Gross, Biochim. Biophys. Acta. 930 19-32 (1987).
19. P.C. Robinson, D.R. Voelker, and R.J. Mason, Am. Rev. Respir. Dis. 130 1156-1160 (1984).
20. P.J. Barnes, Am. J. Respir. Crit. Care Med. 152 838-860 (1995).
21. Y. Isohama, T. Matsuo, H. Kai, K. Takahama and T. Miyata, Biochem. Mol. Biol. Internat. 36 561-568 (1995).
22. M. Johnson, Agents Actions 34 79-95 (1991).
23. A.T. Nials, R.A. Coleman, M. Johnson, H.J. Magnussen, K.F. Rabe, and C.J. Vardey, Br. J. Pharmacol. 110 1112-1116 (1993).
24. D.I. Ball, R.T. Brittain, R.A. Coleman, L.H. Denyer, D. Jack, M. Johnson, L.H. Lunts, A.T. Nials, K.E. Sheldrick, and I.F. Skidmore, Br. J. Pharmacol. 104 665-671 (1991).
25. A.T. Nials, D.I. Ball, R.A. Butchers, R.A. Coleman, A.A. Humbles, M. Johnson, and C.J. Vardey, Eur. J. Pharmacol. 251 127-135 (1994).